People diagnosed with mesothelioma who live in Colorado have access to a number of quality health care options. Conventional mesothelioma treatments available in Colorado include surgery, chemotherapy and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients in Colorado.
We have listed top mesothelioma doctors that practice in Colorado as well as the top cancer care centers in the state. A number of local cancer support services have been included as well for your convenience. Read more about health care options available to you in Colorado below.
01. Statistics
Colorado Mesothelioma Statistics
02. Cancer Centers
Top Colorado Mesothelioma Cancer Centers
Quality cancer treatment services are available at the following mesothelioma cancer centers in Colorado. More detailed information about each cancer center is available by clicking on the appropriate a cancer center detail link.
Colorado Mesothelioma Cancer Clinics
03. Doctors
Top Colorado Mesothelioma Doctors
We have compiled a list of mesothelioma doctors that practice in the state of Colorado. Please click on a doctor link to obtain more information about his/her background, areas of expertise, professional affiliations, and office locations.
Colorado Mesothelioma Doctors
Occasionally, mesothelioma patients will travel to other states to meet with top mesothelioma doctors and thoracic surgeons across the country. These experts will usually concentrate on a particular mesothelioma type within their practice.
04. Clinical Trials
Mesothelioma Clinical Trials in Colorado
The following clinical trials are in progress or actively recruiting participants in the state of Colorado:
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Adenocarcinoma, Clear Cell, Gestational Trophoblastic Disease, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell
Last Updated: November 21, 2020
Status: Recruiting
Locations:
Integrated Cancer Repository for Cancer Research
Conditions: Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Esophageal Neoplasms, Endometrial Neoplasms, Thyroid Neoplasms, Mesothelioma, Neuroendocrine Tumors, Salivary Gland Neoplasms, Anus Neoplasms, Gallbladder Neoplasms, Bile Duct Neoplasms, Oropharyngeal Neoplasms, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Vaginal Neoplasms, Urethral Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms, Hereditary Nonpolyposis, Testicular Neoplasms, Intestinal Neoplasms, Hypopharyngeal Neoplasms, Penile Neoplasms, Ureteral Neoplasms, Neoplasms, Plasma Cell, Peritoneal Neoplasms, Paranasal Sinus Neoplasms, Duodenal Neoplasms, Neoplasms, Unknown Primary, Lip Neoplasms, Thymus Neoplasms, Paraproteinemias
Last Updated: November 10, 2020
Status: Recruiting
Locations: Colorado Springs, CO. Denver, CO. Durango, CO. Lakewood, CO. Littleton, CO. Longmont, CO. Louisville, CO. Parker, CO. Pueblo, CO. Westminster, CO. Daytona Beach, FL. DeLand, FL. Orange City, FL. Palm Coast, FL. Aurora, IL. Moline, IL. Yorkville, IL. Fort Wayne, IN. Indianapolis, IN. Indianapolis, IN. Indianapolis, IN. Kokomo, IN. Council Bluffs, IA. Davenport, IA. Spencer, IA. Waterloo, IA. Overland Park, KS. New Orleans, LA. Portland, ME. Randallstown, MD. Westminster, MD. Holyoke, MA. Ann Arbor, MI. Aitkin, MN. Brainerd, MN. Duluth, MN. Duluth, MN. Fergus Falls, MN. Marshall, MN. Joplin, MO. Kansas City, MO. Kansas City, MO. Kansas City, MO. Liberty, MO. Saint Joseph, MO. Kalispell, MT. Missoula, MT. Hastings, NE. Norfolk, NE. North Platte, NE. O'Neill, NE. Omaha, NE. Omaha, NE. Omaha, NE. Scottsbluff, NE. Glens Falls, NY. Utica, NY. Fayetteville, NC. Fargo, ND. Minot, ND. Pittsburgh, PA. Aberdeen, SD. Mitchell, SD. Sioux Falls, SD. Sioux Falls, SD. Yankton, SD. Yankton, SD. Yankton, SD. Rutland, VT. Fredericksburg, VA. Appleton, WI. Brookfield, WI. Franklin, WI. Mequon, WI. Milwaukee, WI. Oshkosh, WI. Racine, WI. Wauwatosa, WI.
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 7, 2020
Status: Recruiting
Locations: Phoenix, AZ. Scottsdale, AZ. Duarte, CA. La Jolla, CA. Los Angeles, CA. Los Angeles, CA. Newport Beach, CA. Aurora, CO. Jacksonville, FL. Chicago, IL. Chicago, IL. Lexington, KY. Baltimore, MD. Baltimore, MD. Boston, MA. Boston, MA. Rochester, MN. Creve Coeur, MO. Saint Louis, MO. Saint Louis, MO. Saint Peters, MO. Durham, NC. Pittsburgh, PA. Dallas, TX.
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Conditions: Carcinoma, Neoplasms, Small Cell Lung Carcinoma, Endometrial Neoplasms, Thyroid Neoplasms, Mesothelioma, Neuroendocrine Tumors, Cholangiocarcinoma, Salivary Gland Neoplasms, Colorectal Neoplasms, Carcinoid Tumor, Anus Neoplasms, Bile Duct Neoplasms, Vulvar Neoplasms, Thyroid Diseases
Last Updated: November 5, 2020
Status: Recruiting
Locations: Duarte, CA. Los Angeles, CA. Aurora, CO. Orlando, FL. Baltimore, MD. Rockville, MD. Boston, MA. Boston, MA. Boston, MA. New Brunswick, NJ. Houston, TX.
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Conditions: Adenocarcinoma, Sarcoma, Mesothelioma
Last Updated: September 30, 2020
Status: Recruiting
Locations: Scottsdale, AZ. Duarte, CA. Santa Monica, CA. Aurora, CO. Atlanta, GA. Chicago, IL. Grand Rapids, MI. Houston, TX. San Antonio, TX.
05. Support Services
Locate Cancer Support Services in Colorado
The following cancer support services may be of help to you while you are receiving treatment for mesothelioma in Colorado. Support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling.
Colorado Treatment Support Services
-
Counseling & Support Groups
- Rocky Mountain Cancer Centers
(Denver)
303-385-2003 - Rocky Mountain Cancer Centers
(Boulder)
303-385-2003 - Rocky Mountain Cancer Centers
(Pueblo)
719-296-6000 - Rocky Mountain Cancer Centers
(Longmont)
303-385-2003 - University of Colorado Health
(Fort Collins)
970-237-7700 - Rocky Mountain Cancer Centers
(Aurora)
303-385-2003 - Dorcy Cancer Center
(Pueblo)
719-557-5423
- Rocky Mountain Cancer Centers
-
Long-Term Housing
- Ray of Hope Cancer Foundation
(Denver)
720-238-5401 - John Zay Guest House
(Colorado Springs)
719-633-8855 - St. Christopher House
(Denver)
720-917-9900 - Brent’s Place
(Aurora)
720-343-2800 - Rocky Mountain Cancer Assistance
(Denver)
720-229-0303
- Ray of Hope Cancer Foundation
-
- Ronald McDonald House(Aurora)720-324-2400
-
Patient Transport
- Memorial Hospital Central
(Colorado Springs)
800-763-4373 - Beo Personal Care
(Pueblo)
719-544-3330 - Colorado Non-Emergency Medical Transportation
(Boulder)
855-264-6368 - Colorado Springs Mobility
(Colorado Springs)
719-385-0200
- Memorial Hospital Central
-
Physical Therapy
- University of Colorado Health
(Fort Collins)
970-237-7700 - Vail Valley Medical Center
(Vail)
970-569-7777 - Oncology Rehab
(Aurora)
720-306-8261 - Oncology Rehab
(Denver)
720-306-8261 - Oncology Rehab
(Englewood)
720-306-8261 - Sarah Cannon Cancer Institute
(Denver)
303-839-6000
- University of Colorado Health